{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T05:02:39Z","timestamp":1787115759335,"version":"build-2736575974"},"reference-count":17,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T00:00:00Z","timestamp":1349049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T00:00:00Z","timestamp":1349049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T00:00:00Z","timestamp":1349049600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T00:00:00Z","timestamp":1349049600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T00:00:00Z","timestamp":1349049600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T00:00:00Z","timestamp":1349049600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T00:00:00Z","timestamp":1349049600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Epidemiology"],"published-print":{"date-parts":[[2012,10]]},"DOI":"10.1016\/j.canep.2012.03.011","type":"journal-article","created":{"date-parts":[[2012,4,24]],"date-time":"2012-04-24T16:33:23Z","timestamp":1335285203000},"page":"e306-e309","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["High serum levels of soluble interleukin-2 receptor in acute myeloid leukemia: Correlation with poor prognosis and CD4 expression on blast cells"],"prefix":"10.1016","volume":"36","author":[{"given":"Kazunori","family":"Nakase","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenkichi","family":"Kita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taiichi","family":"Kyo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kota","family":"Tsuji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoyuki","family":"Katayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canep.2012.03.011_bib0005","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1620\/tjem.168.231","article-title":"The IL-2\/IL-2 receptor system: involvement of a novel receptor subunit, gamma chain, in growth signal transduction","volume":"168","author":"Sugamura","year":"1992","journal-title":"Tohoku J Exp Med"},{"key":"10.1016\/j.canep.2012.03.011_bib0010","first-page":"323","article-title":"Serum interleukin 2 receptor: clinical and biological implications","volume":"3","author":"Pui","year":"1989","journal-title":"Leukemia"},{"key":"10.1016\/j.canep.2012.03.011_bib0015","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/bjc.1987.83","article-title":"Soluble interleukin-2 receptors in the serum of patients with Hodgkin's lymphoma","volume":"55","author":"Pizzolo","year":"1987","journal-title":"Br J Cancer"},{"key":"10.1016\/j.canep.2012.03.011_bib0020","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1093\/ajcp\/92.2.186","article-title":"Increased levels of soluble interleukin-2 receptor in non-Hodgkin's lymphomas","volume":"92","author":"Chilosi","year":"1989","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.canep.2012.03.011_bib0025","doi-asserted-by":"crossref","first-page":"2540","DOI":"10.1182\/blood.V77.11.2540.2540","article-title":"Serum interleukin-2 receptor as index of tumor burden in hairy cell leukemia","volume":"77","author":"Pizzolo","year":"1991","journal-title":"Blood"},{"key":"10.1016\/j.canep.2012.03.011_bib0030","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1182\/blood.V70.2.396.396","article-title":"High serum levels of interleukin 2 receptor in patients with B chronic lymphocytic leukemia","volume":"70","author":"Semenzato","year":"1987","journal-title":"Blood"},{"key":"10.1016\/j.canep.2012.03.011_bib0035","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.1002\/1097-0142(19940601)73:11<2753::AID-CNCR2820731117>3.0.CO;2-X","article-title":"Significance of soluble interleukin-2 receptor levels for evaluation of the progression of adult T-cell leukemia","volume":"73","author":"Kamihira","year":"1994","journal-title":"Cancer"},{"key":"10.1016\/j.canep.2012.03.011_bib0040","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1038\/sj.leu.2404497","article-title":"Clinical and prognostic significance of cytokine receptor expression in adult acute lymphoblastic leukemia: interleukin-2 receptor \u03b1-chain predicts a poor prognosis","volume":"21","author":"Nakase","year":"2007","journal-title":"Leukemia"},{"key":"10.1016\/j.canep.2012.03.011_bib0045","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.cdp.2005.03.001","article-title":"Elevated levels of soluble interleukin-2 receptor in serum of patients with hematological or non-hematological malignancies","volume":"29","author":"Nakase","year":"2005","journal-title":"Cancer Detect Prev"},{"issue":"Suppl.","key":"10.1016\/j.canep.2012.03.011_bib0050","doi-asserted-by":"crossref","first-page":"S93","DOI":"10.1007\/s002800051088","article-title":"Cooperative oncology groups in Japan: experience from the Japan Adult Leukemia Study Group","volume":"42","author":"Ohno","year":"1998","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.canep.2012.03.011_bib0055","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1182\/blood.V71.4.1135.1135","article-title":"Serum interleukin 2 receptor levels in childhood acute lymphoblastic leukemia","volume":"71","author":"Pui","year":"1988","journal-title":"Blood"},{"key":"10.1016\/j.canep.2012.03.011_bib0060","first-page":"273","article-title":"Clinical importance of interleukin-2 receptor alpha chain expression in acute leukemia. The Japanese cooperative group of leukemia\/lymphoma","volume":"21","author":"Nakase","year":"1997","journal-title":"Cancer Detect Prev"},{"key":"10.1016\/j.canep.2012.03.011_bib0065","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1016\/j.ejca.2009.02.021","article-title":"Interleukin-2 receptor alpha-chain (CD25) expression on leukaemic blasts is predictive for outcome and level of residual disease in AML","volume":"45","author":"Terwijn","year":"2009","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.canep.2012.03.011_bib0070","first-page":"249","article-title":"Serum CD4, CD8, and interleukin-2 receptor levels in childhood acute myeloid leukemia","volume":"5","author":"Pui","year":"1991","journal-title":"Leukemia"},{"key":"10.1016\/j.canep.2012.03.011_bib0075","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1002\/pbc.22966","article-title":"Soluble interleukin-2 receptor \u03b1 activation in a Children's Oncology Group randomized trial of interleukin-2 therapy for pediatric acute myeloid leukemia","volume":"57","author":"Lange","year":"2011","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.canep.2012.03.011_bib0080","first-page":"32","article-title":"Serum interleukin-2 (IL-2), soluble IL-2 receptors and tumor necrosis factor-alfa levels are significantly increased in acute myeloid leukemia patients","volume":"5","author":"Cimino","year":"1991","journal-title":"Leukemia"},{"key":"10.1016\/j.canep.2012.03.011_bib0085","first-page":"410","article-title":"Plasma soluble interleukin-2 receptor (sIL-2R) levels in patients with acute leukemia","volume":"34","author":"Moon","year":"2004","journal-title":"Ann Clin Lab Sci"}],"container-title":["Cancer Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877782112000434?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877782112000434?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,24]],"date-time":"2024-12-24T11:09:36Z","timestamp":1735038576000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1877782112000434"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10]]},"references-count":17,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012,10]]}},"alternative-id":["S1877782112000434"],"URL":"https:\/\/doi.org\/10.1016\/j.canep.2012.03.011","relation":{},"ISSN":["1877-7821"],"issn-type":[{"value":"1877-7821","type":"print"}],"subject":[],"published":{"date-parts":[[2012,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"High serum levels of soluble interleukin-2 receptor in acute myeloid leukemia: Correlation with poor prognosis and CD4 expression on blast cells","name":"articletitle","label":"Article Title"},{"value":"Cancer Epidemiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canep.2012.03.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}